Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02956993 · ClinicalTrials.gov registry record · Phase 1
Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)
A Phase 1 study, sponsored by Proteon Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 29
- Enrollment target
NCT02956993 is a Phase 1 study that has completed, run by Proteon Therapeutics. The registered enrollment target is 29 participants.
The verdict
NCT02956993, a Phase 1 study, has completed, sponsored by Proteon Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 29 participants
- Enrollment target
Study Summary
The research study is designed to assess the technical feasibility and safety of a perivascular injection of vonapanitase delivered via micro-infusion catheter to the distal popliteal, tibial or peroneal arteries immediately following successful angioplasty.
Interventions
- DRUG Placebo
- DRUG vonapanitase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2016-11 |
| Est. Completion | 2019-04-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02956993
The ClinicalTrials.gov registry entry for NCT02956993 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Proteon Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02956993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02956993 about?
NCT02956993 is a clinical study titled "Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)". The research study is designed to assess the technical feasibility and safety of a perivascular injection of vonapanitase delivered via micro-infusion catheter to the distal popliteal, tibial or peroneal arteries immediately following successful angioplasty.
What is the current status of trial NCT02956993?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 29 participants. The study started on 2016-11. Estimated completion is 2019-04-30.
What interventions are being tested in trial NCT02956993?
The interventions under investigation include: Placebo (DRUG), vonapanitase (DRUG).
Who is sponsoring clinical trial NCT02956993?
This trial is sponsored by Proteon Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.